BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27994831)

  • 1. Primary Intraosseous Smooth Muscle Tumor of Uncertain Malignant Potential: Original Report and Molecular Characterization.
    Kropp L; Siegal GP; Frampton GM; Rodriguez MG; McKee S; Conry RM
    Rare Tumors; 2016 Nov; 8(4):6507. PubMed ID: 27994831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the literature laparoscopic surgery for metastatic hepatic leiomyosarcoma associated with smooth muscle tumor of uncertain malignant potential: Case report.
    Fukui K; Takase N; Miyake T; Hisano K; Maeda E; Nishimura T; Abe K; Kozuki A; Tanaka T; Harada N; Takamatsu M; Kaneda K
    World J Hepatol; 2018 Apr; 10(4):402-408. PubMed ID: 29713398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis.
    Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K
    Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uterine fibroid associated with smooth muscle tumor of uncertain malignant potential (STUMP): about a case].
    Saoud MK; Benchiba I; Mamouni N; Errarhay S; Bouchikhi C; Banani A
    Pan Afr Med J; 2018; 31():151. PubMed ID: 31086612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.
    Dall'Asta A; Gizzo S; Musarò A; Quaranta M; Noventa M; Migliavacca C; Sozzi G; Monica M; Mautone D; Berretta R
    Int J Clin Exp Pathol; 2014; 7(11):8136-42. PubMed ID: 25550862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed novel nomenclature of vulvar smooth muscle tumors; a case of Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) of the vulva.
    Viau M; Plante M; Renaud MC; Grondin K; Morin C
    Gynecol Oncol Rep; 2017 May; 20():1-3. PubMed ID: 28180147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma.
    Shapiro A; Ferenczy A; Turcotte R; Bruchim I; Gotlieb WH
    Gynecol Oncol; 2004 Sep; 94(3):818-20. PubMed ID: 15350379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
    Mowers EL; Skinner B; McLean K; Reynolds RK
    J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.
    Conconi D; Chiappa V; Perego P; Redaelli S; Bovo G; Lavitrano M; Milani R; Dalprà L; Lissoni AA
    Oncol Rep; 2017 Jan; 37(1):41-47. PubMed ID: 28004108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Leiomyosarcoma of the Lower Limb Following Uterine Smooth Muscle Tumor of Uncertain Malignant Potential.
    García-Sánchez JM; Bauza M; Pérez-García A; Mayordomo Aranda E; Ruiz Valls A
    Clin Med Insights Case Rep; 2019; 12():1179547619857680. PubMed ID: 31258342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth muscle tumor of uncertain malignant potential (STUMP): a clinicopathologic analysis of 26 cases.
    Zheng YY; Liu XB; Mao YY; Lin MH
    Int J Clin Exp Pathol; 2020; 13(4):818-826. PubMed ID: 32355532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin expression in uterine smooth muscle tumors.
    Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
    Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine smooth muscle tumor of uncertain malignant potential (STUMP) ABOUT a CASE.
    Amal C; Fadwa A; Aicha G; Boufetal H; Mahdaoui S; Samouh N
    Int J Surg Case Rep; 2024 Apr; 117():109556. PubMed ID: 38518473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal smooth muscle tumor of uncertain malignant potential after hysterectomy: a case report.
    Won HS; Chun HG; Lee K
    J Med Case Rep; 2011 May; 5():214. PubMed ID: 21619667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
    Yilmaz A; Rush DS; Soslow RA
    Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
    Shanes ED; Friedman LA; Mills AM
    Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): A single center experience.
    Karataşlı V; Çakır İ; Ayaz D; Budak A; Sancı M
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):637-642. PubMed ID: 30898630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.